blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3215142

EP3215142 - IMMUNOREGULATORY AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.02.2022
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  19.02.2021
FormerGrant of patent is intended
Status updated on  28.10.2020
FormerExamination is in progress
Status updated on  07.09.2019
FormerRequest for examination was made
Status updated on  11.08.2017
FormerThe international publication has been made
Status updated on  28.04.2017
Most recent event   Tooltip19.12.2025Lapse of the patent in a contracting state
New state(s): TR		published on 21.01.2026  [2026/04]
Applicant(s)For all designated states
Flexus Biosciences, Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
[2021/12]
Former [2017/37]For all designated states
Flexus Biosciences, Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
Inventor(s)01 / BECK, Hilary Plake
115 Springdale Way
Emerald Hills, California 94062 / US
02 / JAEN, Juan Carlos
154 Los Robles Drive
Burlingame, California 94010 / US
03 / OSIPOV, Maksim
200 Irene Court Apt. 35
Belmont, California 94002 / US
04 / POWERS, Jay Patrick
745 Rockaway Beach Avenue
Pacifica, California 94044 / US
05 / REILLY, Maureen Kay
2151 Carlmont Drive Apt. 301
Belmont, California 94002 / US
06 / SHUNATONA, Hunter Paul
79 Melrose Avenue
San Francisco, California 94131 / US
07 / WALKER, James Ross
123 Newbridge Street
Menlo Park, California 94025 / US
08 / ZIBINSKY, Mikhail
324 Ravenwood Way
Lodi, California 95240 / US
09 / BALOG, James Aaron
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
10 / WILLIAMS, David K.
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
11 / MARKWALDER, Jay A.
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
12 / SEITZ, Steven P.
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
13 / CHERNEY, Emily Charlotte
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
14 / ZHANG, Liping
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
15 / SHAN, Weifang
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
16 / GUO, Weiwei
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
17 / HUANG, Audris
c/o Flexus Biosciences Inc.
Route 206 and Province Line Road
Princeton, New Jersey 08540 / US
 [2017/37]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2021/12]
Former [2017/37]Reitstötter Kinzebach
Patentanwälte
Sternwartstrasse 4
81679 München / DE
Application number, filing date15857810.405.11.2015
[2017/37]
WO2015US59316
Priority number, dateUS201462075678P05.11.2014         Original published format: US 201462075678 P
[2017/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2016073774
Date:12.05.2016
Language:EN
[2016/19]
Type: A2 Application without search report 
No.:EP3215142
Date:13.09.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 12.05.2016 takes the place of the publication of the European patent application.
[2017/37]
Type: B1 Patent specification 
No.:EP3215142
Date:24.03.2021
Language:EN
[2021/12]
Search report(s)International search report - published on:US07.07.2016
(Supplementary) European search report - dispatched on:EP07.08.2018
ClassificationIPC:A61K45/06, A61K31/136, A61K31/166, A61K31/277, A61K31/4412, A61K31/445, A61K31/47, A61K31/4709, A61K31/496, A61K31/497, A61K31/506, A61K31/519, A61K31/5377, A61K31/381, A61P35/00
[2020/47]
CPC:
A61K31/166 (EP,KR,US); C07C255/60 (KR); A61K31/00 (US);
A61K31/136 (EP,US); A61K31/277 (EP,US); A61K31/381 (EP,US);
A61K31/4412 (EP,US); A61K31/445 (EP,KR,US); A61K31/47 (EP,KR,US);
A61K31/4709 (EP,US); A61K31/496 (EP,US); A61K31/497 (EP,US);
A61K31/506 (EP,US); A61K31/519 (EP,US); A61K31/5377 (EP,US);
A61K45/06 (EP,US); A61P35/00 (EP,US); C07C211/45 (US);
C07C217/80 (EP,US); C07C233/10 (EP,US); C07C233/59 (EP,US);
C07C233/60 (EP,US); C07C233/65 (US); C07C233/74 (EP,US);
C07C255/50 (US); C07C255/58 (EP,US); C07C275/30 (EP,US);
C07D211/08 (EP,US); C07D211/16 (EP); C07D211/46 (EP);
C07D213/40 (EP); C07D213/68 (EP,US); C07D213/81 (EP);
C07D215/04 (EP,US); C07D215/12 (EP); C07D215/233 (EP,US);
C07D401/04 (EP); C07D401/12 (EP); C07D413/06 (EP);
C07D417/12 (EP); C07D487/04 (EP,US); A61K2300/00 (US);
C07C2601/14 (EP,US); C07K16/18 (US) (-)
C-Set:
A61K31/136, A61K2300/00 (US,EP);
A61K31/166, A61K2300/00 (US,EP);
A61K31/277, A61K2300/00 (US,EP);
A61K31/381, A61K2300/00 (US,EP);
A61K31/4412, A61K2300/00 (US,EP);
A61K31/445, A61K2300/00 (US,EP);
A61K31/4709, A61K2300/00 (US,EP);
A61K31/47, A61K2300/00 (US,EP);
A61K31/496, A61K2300/00 (US,EP);
A61K31/497, A61K2300/00 (EP,US);
A61K31/506, A61K2300/00 (EP,US);
A61K31/519, A61K2300/00 (EP,US);
A61K31/5377, A61K2300/00 (US,EP)
(-)
Former IPC [2017/37]A61K31/16, C07C13/02, C07C13/16
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/37]
Extension statesBA27.04.2017
ME27.04.2017
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:IMMUNREGULATORISCHE WIRKSTOFFE[2017/37]
English:IMMUNOREGULATORY AGENTS[2017/37]
French:AGENTS IMMUNORÉGULATEURS[2017/37]
Entry into regional phase27.04.2017National basic fee paid 
27.04.2017Search fee paid 
27.04.2017Designation fee(s) paid 
27.04.2017Examination fee paid 
Examination procedure27.04.2017Examination requested  [2017/37]
27.04.2017Date on which the examining division has become responsible
04.03.2019Amendment by applicant (claims and/or description)
11.09.2019Despatch of a communication from the examining division (Time limit: M04)
21.01.2020Reply to a communication from the examining division
16.04.2020Despatch of a communication from the examining division (Time limit: M02)
01.06.2020Reply to a communication from the examining division
29.10.2020Communication of intention to grant the patent
02.02.2021Fee for grant paid
02.02.2021Fee for publishing/printing paid
02.02.2021Receipt of the translation of the claim(s)
Opposition(s)04.01.2022No opposition filed within time limit [2022/10]
Fees paidRenewal fee
13.11.2017Renewal fee patent year 03
14.11.2018Renewal fee patent year 04
14.11.2019Renewal fee patent year 05
13.11.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.11.2015
AL24.03.2021
AT24.03.2021
CY24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
MK24.03.2021
MT24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
TR24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE05.11.2021
LU05.11.2021
BE30.11.2021
CH30.11.2021
LI30.11.2021
[2026/04]
Former [2024/41]HU05.11.2015
AL24.03.2021
AT24.03.2021
CY24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
MK24.03.2021
MT24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE05.11.2021
LU05.11.2021
BE30.11.2021
CH30.11.2021
LI30.11.2021
Former [2024/22]HU05.11.2015
AL24.03.2021
AT24.03.2021
CY24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
MK24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE05.11.2021
LU05.11.2021
BE30.11.2021
CH30.11.2021
LI30.11.2021
Former [2023/30]HU05.11.2015
AL24.03.2021
AT24.03.2021
CY24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE05.11.2021
LU05.11.2021
BE30.11.2021
CH30.11.2021
LI30.11.2021
Former [2023/28]HU05.11.2015
AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE05.11.2021
LU05.11.2021
BE30.11.2021
CH30.11.2021
LI30.11.2021
Former [2022/48]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
IE05.11.2021
LU05.11.2021
BE30.11.2021
CH30.11.2021
LI30.11.2021
Former [2022/37]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
LU05.11.2021
BE30.11.2021
CH30.11.2021
LI30.11.2021
Former [2022/34]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
LU05.11.2021
BE30.11.2021
Former [2022/33]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
MC24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
BE30.11.2021
Former [2022/23]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2022/13]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SI24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
PT26.07.2021
IS24.12.2021
Former [2022/10]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
PT26.07.2021
IS24.12.2021
Former [2022/08]AL24.03.2021
AT24.03.2021
CZ24.03.2021
DK24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2022/07]AL24.03.2021
AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2021/52]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
PL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2021/51]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
IS24.07.2021
PT26.07.2021
Former [2021/50]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
RO24.03.2021
RS24.03.2021
SE24.03.2021
SK24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
PT26.07.2021
Former [2021/48]AT24.03.2021
CZ24.03.2021
EE24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
RS24.03.2021
SE24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/46]AT24.03.2021
FI24.03.2021
HR24.03.2021
LT24.03.2021
LV24.03.2021
NL24.03.2021
RS24.03.2021
SE24.03.2021
SM24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/43]FI24.03.2021
HR24.03.2021
LV24.03.2021
NL24.03.2021
RS24.03.2021
SE24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/38]FI24.03.2021
HR24.03.2021
LV24.03.2021
RS24.03.2021
SE24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/37]FI24.03.2021
HR24.03.2021
LV24.03.2021
RS24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/36]FI24.03.2021
HR24.03.2021
BG24.06.2021
NO24.06.2021
GR25.06.2021
Former [2021/35]FI24.03.2021
HR24.03.2021
NO24.06.2021
Former [2021/33]FI24.03.2021
NO24.06.2021
Documents cited:Search[A] WO2007095050  (INCYTE CORP et al.) [A] 1-3,5-12 * pages 30-32 *
 [X] WO2010094126  (MERCK FROSST CANADA LTD et al.) [X] 1,2,5-12 * page 1; example -; claim 1 *
 [X] WO2013086002  (CELLWORKS RES INDIA PRIVATE LTD et al.) [X] 1,2,5-12 * page 22; claim 4 *
 [X] WO2012158784   [X] 1,2,5-12 * example -; claim 1 *
 [X] WO2008077554  (SANOFI AVENTIS et al.) [X] 1,2,5-12 * page 75; claim 1 *
 [X] US2005176764  (MATAKI CHIKAGE et al.) [X] 1,2,5-12 * pages 34,54,55; claim 1 *
 [X] WO2008133975  (AVALON PHARMACEUTICALS et al.) [X] 1,2,5-12 * example -; claim - *
 [X] US2009023773  (VOHRA RAHUL et al.) [X] 1,2,5-12 * paragraph [0029]; example -; claim 1 *
 [X] WO2007082079   [X] 1,2,5-12 * example -; claim - *
 [X] WO2007044085  (XENON PHARMACEUTICALS INC et al.) [X] 1,2,5-12 * page 32; example -; claim 1 *
 [X] WO2014007998  (UNIV CALIFORNIA et al.) [X] 1,2,5-12 * example -; claim - *
 [X] WO2014001247  (BAYER PHARMA AG et al.) [X] 1,2,5-12 * example -; claim - *
 [X] WO2004047755  (TULARIK INC et al.) [X] 1,2,5-12 * page 120; example 129 * * claim 27 *
 [X] WO2006135649  (JANSSEN PHARMACEUTICA NV et al.) [X] 1,2,5-12 * example -; claim - *
 [X] WO03076421  (JANSSEN PHARMACEUTICA NV et al.) [X] 1,2,5-12 * example -; claim - *
 [X] WO2013041457  (MSD OSS BV et al.) [X] 1,2,5-12 * example -; claim 9 *
 [X] WO0220474  (PFIZER PROD INC et al.) [X] 1,2,5-12 * example - *
 [X] EP1884510  (DAINIPPON SUMITOMO PHARMA CO et al.) [X] 1,2,5-12 * page 39 *
 [X] WO2008156717  (MERCK & CO INC et al.) [X] 1,2,5-12 * example - *
 [X] WO2009052320  (UNIV NORTHEASTERN et al.) [X] 1,2,5-12 * pages 44-45 *
 [X] WO2007137107  (ABBOTT LAB et al.) [X] 1,2,5-12 * page 30; example - *
 [X] US6291499  (THOMPSON WAYNE et al.) [X] 1,2,5-12 * example - *
 [X] US2008221175  (YUAN CHESTER CHENGUANG et al.) [X] 1,2,5-12 * example - *
 [X] WO2005110976  (GRUENENTHAL GMBH et al.) [X] 1,2,5-12 * example - *
 [X] WO2009151800  (MERCK & CO INC et al.) [X] 1,2,5-12 * page 11; example -; claim - *
 [X] EP0497303  (KYORIN SEIYAKU KK et al.) [X] 1,2,5-12 * example -; claim - *
 [X] WO0071171  (UNIV WAKE FOREST et al.) [X] 1,2,5-12 * example -; claim - *
 [X] EP1217000  (AVENTIS PHARMA GMBH et al.) [X] 1,2,5-12 * example -; claim - *
 [E] WO2015188085  (FLEXUS BIOSCIENCES INC et al.) [E] 1-3 * pages 59,74 * * pages 79-81; example - *
 [X]   HUANG ET AL: "Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptors", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 41, 1 January 1998 (1998-01-01), pages 2361 - 2370, XP002154246, ISSN: 0022-2623, DOI: 10.1021/JM980032L [X] 1,2,5-12 * table 1 *

DOI:   http://dx.doi.org/10.1021/jm980032l
International search[X] US2003190298  (BRADLEY STUART E et al.) [X] 1, 15 * ; paragraph [0109] *
 [X] US2013197095  (NOLTE BERT et al.) [X] 1, 17-18 * ; paragraphs [0436]-[0437] *
 [X] WO2004054974  (SMITHKLINE BEECHAM CORP et al.) [X] 1, 19 * ; page 50, lines 10-15 *
 [XY] WO2009052320  (UNIV NORTHEASTERN et al.) [X] 1, 20, 23, 30-31 * ; abstract; paragraphs [0012], [0020], [0024] [0078], [0102], [0360]-[0361] *[Y] 26-29, 32-33, 34/32-33
 [X] EP0596298  (BAYER AG et al.) [X] 1, 21 * ; paragraph [0110] *
 [X] EP1781656  (SANOFI AVENTIS DEUTSCHLAND et al.) [X] 1, 22 * ; paragraph [0125] *
 [XY] WO2005080317  (PFIZER JAPAN INC et al.) [X] 1-8, 25 * ; abstract; page 15, paragraph 2; page 16, paragraph 1; page 17, paragraph 3; page 29, paragraphs 4-5; page 78, paragraphs 4-5; page 85, paragraphs 2-3 *[Y] 9-14, 16, 24
 [Y] US5455273  (MAIER ROLAND et al.) [Y] 9-13 * ; column 11, lines 50-55; column 22, lines 15-20 *
 [Y] WO2010015655  (NOVARTIS AG et al.) [Y] 1, 14 * ; page 26, lines 10-15; page 97, lines 1-20; *
 [Y] US2013217706  (TRAN THUY-ANH et al.) [Y] 1, 16 * ; paragraphs [0049], [0643] *
 [Y] WO2014150677  (BRISTOL MYERS SQUIBB CO et al.) [Y] 26-29 * ; abstract; page 1, lines 20-30; page 107, lines 15-22 *
 [Y] WO2014160967  (BIOMED VALLEY DISCOVERIES INC et al.) [Y] 32-33, 34/32-33 * ; paragraphs [0032], [0052], [0079], [0101]; claim 31 *
 [Y]   DATABASE PUBCHEM 22 May 2013 (2013-05-22), Database accession no. SID162741420 [Y] 1, 24 * ; page 3 *
by applicantWO9929310
 WO2004094409
 WO2007095050
 WO2005080317
 WO0192204
   SERAFINI, P. ET AL., SEMIN. CANCER BIOL., vol. 16, no. 1, February 2006 (2006-02-01), pages 53 - 65
   BALL, H.J. ET AL., GENE, vol. 396, no. 1, 1 July 2007 (2007-07-01), pages 203 - 213 [Y] 9-14, 16, 24
   BRANDACHER, G. ET AL., CLIN. CANCER RES., vol. 12, no. 4, 15 February 2006 (2006-02-15), pages 1144 - 1151
   YAMAMOTO, T. ET AL., J. ORGANOMET. CHEM., vol. 694, 2009, pages 1325 - 1332
   LI, G. ET AL., BIOORG. MED. CHEM. LETT., vol. 18, 2008, pages 1146 - 1150
   BIOORG. MED. CHEM. LETT., vol. 24, 2014, pages 5377 [Y] 1, 24 * ; page 3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.